http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112390855-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
filingDate | 2019-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112390855-B |
titleOfInvention | Application of Pretide-146a in preparation of medicine for relieving or treating autoimmune diseases |
abstract | The invention provides application of Pretide-146a in preparation of a medicine for relieving or treating autoimmune diseases. The invention discloses a novel functional small peptide, which is named Pretide-146 a. The Pretide-146a can inhibit abnormal activation of a type I interferon pathway, and can be applied to relieving or treating autoimmune diseases, such as systemic lupus erythematosus and complications thereof. The Pretide-146a peptide also has the advantages of easy synthesis, small toxicity, lasting effect, stable effect and the like. |
priorityDate | 2019-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 216.